BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Janssen Pharmaceutica’s Investigational Darunavir-Based Single-Tablet Regimen Shows Positive Results in Previously Untreated HIV Patients in Pivotal Phase 3 AMBER Clinical Trial

  Janssen Pharmaceutica, NV today announced that the pivotal Phase III AMBER study achieved its primary endpoint, which focused on virologic response rate.

  October 25, 2017

   · 

  6 min read
• 

  Policy

  Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for INVELTYSTM (KPI-121 1%)

  The drug is a topical twice-a-day product candidate for the treatment of inflammation and pain in patients who have undergone ocular surgery.

  October 25, 2017

   · 

  7 min read
• Business

  BIOLASE to Host 2017 Third Quarter Financial Results Conference Call on November 1

  BIOLASE, Inc., the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, November 1, 2017, at 4:30 p.m. Eastern Time.

  October 25, 2017

   · 

  2 min read
• Genetown

  Arrakis Therapeutics Announces Release of SHAPEware Bioinformatics Tools as Open-Source Software

  Arrakis Therapeutics announced that it has released SHAPEware as open-source software for the research community with the goal of promoting and facilitating the use of SHAPE-based approaches to study RNA structure.

  October 25, 2017

   · 

  4 min read
• Genetown

  ImmusanT Announces Acceptance of Late Breaking Celiac Interleukin Data at United European Gastroenterology (UEG) Week

  ImmusanT today announced data from a study evaluating cytokine levels following gluten ingestion in celiac disease (CeD) and non-celiac gluten sensitive (NCGS) patients has been accepted as a “late breaker” at United European Gastroenterology (UEG) Week.

  October 25, 2017

   · 

  4 min read
• Business

  Amerigen and Biophore Collaborate on Penicillamine Generics

  Amerigen Pharma and Biophore today announced that they are collaborating to bring a generic version of Valeant’s Cuprimine and other penicillamine based generic products to the U.S. market using active pharmaceutical ingredient supplied by Biophore from India.

  October 25, 2017

   · 

  1 min read
• Business

  Parkinson’s Foundation Welcomes Two New Board Members

  The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

  October 25, 2017

   · 

  2 min read
• CathWorks Announces FAST-FFR Pivotal Clinical Trial

  Cathworks announced today that the first patient has been enrolled in the FAST-FFR clinical trial.

  October 25, 2017

   · 

  2 min read
• FDA

  RadiaDyne Snags Clearance for Two Additional FDA Indications for the OARtrac System

  RadiaDyne announces it received notice of additional FDA clearance for two new Indications of Use for their upcoming OARtrac radiation dose monitoring platform.

  October 25, 2017

   · 

  2 min read
• Business

  Thermo Fisher Scientific Reports Third Quarter 2017 Results

  Thermo Fisher Scientific today reported its financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  56 min read